Veterinary application of in vitro dissolution data and the Biopharmaceutics Classification System

Pharmacopeial Forum

Volumn 30, Issue 6, 2004, Pages 2295-2302

  Martinez, Marilyn N ^a   Papich, Mark G ^a   Riviere, Jim E ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 27444447602     PISSN: 03634655     EISSN: 15421945     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Amidon, GL, Lennemas, H, Shah, VP, and Crison, JR. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res. 1995;12:413-420.
2. Rekhi, GS, Eddington, ND, Fossler, MJ, Schwartz, P, Lesko, LJ, Augsburger, LL. Evaluation of in vitro release rate and in vivo absorption characteristics of four metoprolol tartrate immediate-release tablet formulations. Pharm Dev Technol. 1997;2:11-24.
3. Eddington, ND, Ashraf, M, Augsburger, LL, Leslie, JL, Fossler, MJ, Lesko, L, et al. Identification of formulation and manufacturing variables that influence in vitro dissolution and in vivo bioavailability of propranolol hydrochloride tablets. Pharm Dev Technol. 1998;3:525-547.
4. Piscitelli, DA, Bigora, S, Propst, C, Goskonda, S, Schwartz, P, Lesko, LJ, et al. The impact of formulation and process changes on in vitro dissolution and bioequivalence of piroxicam capsules. Pharm Dev Technol. 1998;3:443-452.
5. Yu, LX, Crison, JR, Lipka, E, and Amidon, GL. Transport approaches to the biopharmaceutical design of oral drug delivery systems: prediction of intestinal absorption. Adv Drug Del Rev. 1996;19:359-376.
6. Yu, LX. An integrated model for determining causes of poor oral drug absorption. Pharm Res. 1999;16:1883-1887.
7. FDA Guidance for Industry, CDER, "Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System" (August 2000).
8. USP 27-NF 22. General Chapter 〈711〉 Dissolution. United States Pharmacopeial Convention Inc., 12601 Twinbrook Parkway, Rockville Maryland: 2004.
9. Lipka, E, and Amidon, GL. Setting bioequivalence requirements for drug development based on preclinical data: optimizing oral drug delivery systems. J Cont Rel. 1999;62:41-49.
10. Kasim NA, Whitehouse M, Ramachandran C, Bermejo, et al. Molecular properties of WHO essential drugs and provisional biopharmaceutical classification, (in press, 2004).
11. Dressman JB. Comparison of canine and human gastrointestinal physiology. Pharm Res. 1986;3:123-131.
12. Chiou WL, Jeong HY, Chung SM, and Wu TC. Evaluation of using dog as an animal model to study the fraction of oral dose absorbed of 43 drugs in humans. Pharm Res. 2000;17:135-140.
13. Sabnis S. Factors influencing the bioavailability of peroral formulations of drugs for dogs. Vet Res Com. 1999;23:425-447.
14. Kararli TT. Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals. Biopharm Drug Dispos. 1995;16:351-380.
15. Lin JH. Species similarities and differences in pharmacokinetics. Drug Metab Disp. 1995;23:1008-1021.
16. Stevens CE, Humes, ID. Comparative Physiology of the Vertebrate Digestive System. Cambridge University Press. (1995).
17. Akimoto M, Nagahata, N, Furuya, A, Fukushima, K, Higuchi, S, Suwa, T. Gastric pH profiles of beagle dogs and their use as an alternative to human testing. Eur J Pharm Biopharm. 2000;49:99-102.
18. Youngberg CA, Wlodyga, J, Schmaltz, S, Dressman, JB. Radiotelemetric determination of gastrointestinal pH in four healthy beagles. Am J Vet Res. 1985;46:1516-1521.
19. Aoyagi N, Ogata, H, Kaniwa, N, Ejima, A. Bioavailability of indomethacin capsules in humans. (I): bioavailability and effects of gastric acidity. Int J Clin Pharmacol Ther Toxicol. 1985;9:469-474.
20. Ogata H, Aoyagi N, Kaniwa N, Ejima, A. Effect of food on bioavailability of metronidazole from sugar-coated tablets having different dissolution rates in subjects with low gastric acidity. Int J Clin Pharmacol Ther Toxicol. 1986;6:279-282.
21. Tokumura T, Tsushima, Y, Tatsuishi, K, Kayano, M, Machida, Y, Nagai T. Enhancement of the oral bioavailability of cinnarizine in oleic acid in beagle dogs. J Pharm Sci. 1987;76:286-288.
22. Lin JH, Chen, IW, Vastag, KJ, Ostovic, D. pH-dependent oral absorption of L-735, 524, a potent HIV protease inhibitor, in rats and dogs. Drug Metab Disp. 1995;23:1730-735.
23. Bach FJ, KuKanich B, Papich MG, McKieman BC. Evaluation of the bioavailability and pharmacokinetics of two extended-release theophylline formulations in dogs. J Am Vet Med Assn. 2004;224:1113-1119.
24. Devereux JE, Newton, JM, Short, MB. The influence of density on the gastrointestinal transit of pellets. J Pharm Pharmacol. 1990;7:500-501.
25. Meyer, J, Dressman, JB, Fink, A, Amidon, GL. Effect of size and density on canine gastric emptying of nondigestible solids. Gastroenterology. 1985;89:805-813.
26. Hinder RA, Kelly KA. Canine gastric emptying of solids and liquids. Am J Physiol. 1977;233:E335-E340
27. Aoyagi N, Ogata, H, Kaniwa, N, Uchiyama, M, Yasuda, Y, Tanioka, Y. Gastric emptying of tablets and granules in humans, dogs, pigs, and stomach-emptying-controlled rabbits, J Pharm Sci. 1992;81:1170-1174.
28. Kaniwa N, Aoyagi, N, Ogata H, Ejima, A. Gastric emptying rates of drug preparations. I. Effects of size of dosage forms, food, and species on gastric emptying rates, J Pharmacobiodyn. 1988;11:563-570.
29. Nap RC, Breen DJ, Lam TJGM, DeBruyne JJ. Gastric retention of enteric-coated aspirin tablets in beagle dogs. J Vet Pharmacol Therapent. 1990;13:148-153.